CoChat

Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis

Open access
Huang, Xiaozhong, Sun, Jia, Chen, Gen, Niu, Chao, Wang, Ying, Zhao, Congcong, Sun, Jian, Huang, Huiya, Huang, Shuai, Liang, Yangzhi, Shen, Yingjie, Cong, Weitao, Jin, Litai, Zhu, Zhongxin · 2019 · Frontiers in Pharmacology
Cited by 200

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background/Aims: Diabetic foot ulcers (DFUs) represent a serious challenge in clinical practice, in which the hyperglycemia-induced disturbance of angiogenesis and endothelial dysfunction play a crucial role. Resveratrol (RES), a potential agonist of silent information regulator 1 (SIRT1), can improve endothelial function and has strong pro-angiogenic properties, thus becoming a research focus for the treatment of DFUs; however, the underlying mechanism by which RES regulates these processes remains unclear. Therefore, we aimed to investigate whether RES exerts its protective role in diabetic wound healing by alleviating hyperglycemia-induced endothelial dysfunction and the disturbance of angiogenesis. Methods: We investigated the effects of RES on cell migration, proliferation, apoptosis, tube formation, and the underlying molecular mechanisms in high glucose (33 mM)-stimulated human umbilical vein endothelial cells (HUVECs) by semi-quantitative RT-PCR, western blot analysis, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, and immunofluorescence in vitro. We further explored the role of RES on endothelial dysfunction and wound healing disturbance in db/db mice by TUNEL staining, immunofluorescence, and photography in vivo. Results: We observed an obvious inhibition of hyperglycemia-triggered endothelial dysfunction and a disturbance of angiogenesis, followed by the promotion of diabetic wound healing via RES, along with restoration of the activity of the hyperglycemia-impaired SIRT1 signaling pathway. Pretreatment with EX-527, a SIRT1 inhibitor, abolished the RES-mediated endothelial protection and pro-angiogenesis action, and then delayed diabetic wound healing. Furthermore, examination of the overexpression of a transcription factor substrate of SIRT1, forkhead box O1 (FOXO1), in HUVECs and db/db mice revealed that RES activated SIRT1 to restore hyperglycemia-triggered endothelial dysfunction and disturbance of angiogenesis, followed by the promotion of diabetic wound healing in a c-Myc-dependent manner. Pretreatment with 10058-F4, a c-Myc inhibitor, repressed RES-mediated endothelial protection, angiogenesis, and diabetic wound healing. Conclusion: Our findings indicate that the positive role of RES in diabetic wound healing via its SIRT1-dependent endothelial protection and pro-angiogenic effects involves the inhibition of FOXO1 and the de-repression of c-Myc expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fphar.2019.00421

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Huang, X., Sun, J., Chen, G., Niu, C., Wang, Y., Zhao, C., Sun, J., Huang, H., Huang, S., Liang, Y., Shen, Y., Cong, W., Jin, L., & Zhu, Z.
Venue
Frontiers in Pharmacology
Published
2019-04-24
Volume
10
Pages
421-421
ISSN
1663-9812 (ISSN-L)
OpenAlex
W2940511845
Cited by
200
References
8
FWCI
9.33
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis. https://app.cochat.ai/papers/10.3389/fphar.2019.00421
The paper
Huang, X., Sun, J., Chen, G., Niu, C., Wang, Y., Zhao, C., Sun, J., Huang, H., Huang, S., Liang, Y., Shen, Y., Cong, W., Jin, L., & Zhu, Z. (2019). Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2019.00421

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.